JP2023523414A5 - - Google Patents

Info

Publication number
JP2023523414A5
JP2023523414A5 JP2022563870A JP2022563870A JP2023523414A5 JP 2023523414 A5 JP2023523414 A5 JP 2023523414A5 JP 2022563870 A JP2022563870 A JP 2022563870A JP 2022563870 A JP2022563870 A JP 2022563870A JP 2023523414 A5 JP2023523414 A5 JP 2023523414A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
self
acid sequence
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022563870A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023523414A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/028486 external-priority patent/WO2021216776A2/en
Publication of JP2023523414A publication Critical patent/JP2023523414A/ja
Publication of JP2023523414A5 publication Critical patent/JP2023523414A5/ja
Pending legal-status Critical Current

Links

JP2022563870A 2020-04-21 2021-04-21 キャッピング化合物、組成物、及びその使用方法 Pending JP2023523414A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063013456P 2020-04-21 2020-04-21
US63/013,456 2020-04-21
US202063020473P 2020-05-05 2020-05-05
US63/020,473 2020-05-05
PCT/US2021/028486 WO2021216776A2 (en) 2020-04-21 2021-04-21 Capping compounds, compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2023523414A JP2023523414A (ja) 2023-06-05
JP2023523414A5 true JP2023523414A5 (cg-RX-API-DMAC7.html) 2024-05-01

Family

ID=78269927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563870A Pending JP2023523414A (ja) 2020-04-21 2021-04-21 キャッピング化合物、組成物、及びその使用方法

Country Status (9)

Country Link
US (1) US20230303614A1 (cg-RX-API-DMAC7.html)
EP (1) EP4138854A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023523414A (cg-RX-API-DMAC7.html)
KR (1) KR20230015914A (cg-RX-API-DMAC7.html)
CN (1) CN115768437A (cg-RX-API-DMAC7.html)
AU (1) AU2021260932A1 (cg-RX-API-DMAC7.html)
CA (1) CA3173803A1 (cg-RX-API-DMAC7.html)
IL (1) IL296855A (cg-RX-API-DMAC7.html)
WO (1) WO2021216776A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3198727A1 (en) * 2020-10-20 2022-04-28 St Pharm Co., Ltd. Oligonucleotide for 5'-capped rna synthesis
CN118978560A (zh) * 2021-08-27 2024-11-19 上海兆维科技发展有限公司 一种加帽类似物及其应用
IL312557A (en) * 2021-11-08 2024-07-01 Gritstone Bio Inc Self-amplifying RNA compounds and methods of using them
US20250108066A1 (en) * 2022-01-27 2025-04-03 Trilink Biotechnologies, Llc Trinucleotide cap analogs and methods of use thereof
CN115260264B (zh) * 2022-02-28 2023-06-09 广州市恒诺康医药科技有限公司 用于rna加帽的化合物及其应用
EP4522754A1 (en) * 2022-05-12 2025-03-19 Sunvax MRNA Therapeutics Inc. Synthetic self-amplifying mrna molecules with secretion antigen and immunomodulator
IL319652A (en) * 2022-10-04 2025-05-01 BioNTech SE RNA structures and their uses
WO2025037891A1 (ko) * 2023-08-14 2025-02-20 에스티팜 주식회사 5'-캡핑된 rna 합성용 올리고뉴클레오티드
CN120082547B (zh) * 2025-05-06 2025-10-03 北京悦康科创医药科技股份有限公司 用于自复制mRNA的加帽类似物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2259177T3 (es) * 1990-08-13 2006-09-16 Isis Pharmaceuticals, Inc. Oligonucleotidos modificados en el azucar que detectan y modulan la expresion genica.
DK4276189T3 (da) * 2015-09-21 2026-05-26 Trilink Biotechnologies Llc Initierende oligonukleotidprimere med kappe til syntesering af 5'-ende RNA'er med kappe
WO2017208191A1 (en) * 2016-06-02 2017-12-07 Glaxosmithkline Biologicals Sa Zika viral antigen constructs
US10487105B2 (en) * 2016-10-19 2019-11-26 Arcturus Therapeutics, Inc. Trinucleotide MRNA cap analogs
RU2019119272A (ru) * 2016-11-23 2020-12-24 Гритстоун Онколоджи, Инк. Вирусная доставка неоантигенов
KR102945203B1 (ko) * 2017-05-08 2026-03-31 시애틀 프로젝트 코포레이션 알파바이러스 신생항원 벡터
WO2019036682A1 (en) * 2017-08-18 2019-02-21 Modernatx, Inc. RNA VARIANTS POLYMERASE

Similar Documents

Publication Publication Date Title
JP2021525076A5 (cg-RX-API-DMAC7.html)
Zhou et al. Cancer vaccines: current status and future directions
JP2022512912A5 (cg-RX-API-DMAC7.html)
JP2023526495A5 (cg-RX-API-DMAC7.html)
EP3813874A1 (en) Novel lassa virus rna molecules and compositions for vaccination
JP2023541108A5 (cg-RX-API-DMAC7.html)
JP2022534282A5 (cg-RX-API-DMAC7.html)
JP2022539417A5 (cg-RX-API-DMAC7.html)
JP2021524247A5 (cg-RX-API-DMAC7.html)
CN115768437A (zh) 加帽化合物、组合物及其使用方法
JP2023523413A5 (cg-RX-API-DMAC7.html)
JP2023521662A5 (cg-RX-API-DMAC7.html)
CN118556131A (zh) 用于蛋白质表达的mRNA及其模板
CA3236106A1 (en) Modified arenavirus particles expressing mutant kras, mutated cancer driver gene, or tumor-associated antigen as cancer immunotherapies
JP2004501646A5 (cg-RX-API-DMAC7.html)
CN106459997A (zh) 用于疫苗应用的高效价病毒样囊泡的进化
Li et al. mRNA vaccines: current applications and future directions
TW202245809A (zh) 用於治療b型肝炎病毒感染之組合療法
JP2022536945A (ja) B型肝炎ウイルス(HBV)ワクチンおよびHBVを標的化するRNAiの組合せ
JP2024542126A5 (cg-RX-API-DMAC7.html)
Ibragimova et al. mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes
JP2021507707A5 (cg-RX-API-DMAC7.html)
KR20240099240A (ko) 자가 증폭 rna 조성물 및 이의 사용 방법
JP2024546964A5 (cg-RX-API-DMAC7.html)
WO2026081578A1 (zh) 一种自复制mRNA疫苗及其制备方法和用途